Vanguard Fiduciary Trust
KALA icon

Vanguard Fiduciary Trust’s KALA BIO KALA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175K Buy
101,396
+100,803
+16,999% +$489K ﹤0.01% 3612
2026
Q1 		$5.13K Buy
+593
New +$12.5K ﹤0.01% 4028

Other funds holding KALA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust's KALA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its KALA BIO (KALA) stake by 16,999% in Q2 2026, buying an estimated $489K and bringing the position to 101,396 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #3612.

Vanguard Fiduciary Trust first reported a position in KALA in Q1 2026 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • Vanguard Fiduciary Trust held 101,396 shares of KALA BIO worth $175K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 100,803 KALA BIO shares in Q2 2026, an estimated $489K.
  • KALA BIO made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3612 holding.
  • Vanguard Fiduciary Trust first reported a position in KALA BIO in Q1 2026 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.